250 related articles for article (PubMed ID: 26738474)
1. Structure-Driven Developments of 26S Proteasome Inhibitors.
Śledź P; Baumeister W
Annu Rev Pharmacol Toxicol; 2016; 56():191-209. PubMed ID: 26738474
[TBL] [Abstract][Full Text] [Related]
2. [The proteasome - structural aspects and inhibitors: a second life for a validated drug target].
Reboud-Ravaux M
Biol Aujourdhui; 2021; 215(1-2):1-23. PubMed ID: 34397372
[TBL] [Abstract][Full Text] [Related]
3. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
Staszczak M
Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
[TBL] [Abstract][Full Text] [Related]
4. A High-Content Screening Assay for the Discovery of Novel Proteasome Inhibitors from Formosan Soft Corals.
Ling XH; Wang SK; Huang YH; Huang MJ; Duh CY
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30347865
[TBL] [Abstract][Full Text] [Related]
5. Proteasome deubiquitinases as novel targets for cancer therapy.
D'Arcy P; Linder S
Int J Biochem Cell Biol; 2012 Nov; 44(11):1729-38. PubMed ID: 22819849
[TBL] [Abstract][Full Text] [Related]
6. Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition.
Patel K; Ahmed ZS; Huang X; Yang Q; Ekinci E; Neslund-Dudas CM; Mitra B; Elnady FA; Ahn YH; Yang H; Liu J; Dou QP
Future Med Chem; 2018 Sep; 10(17):2087-2108. PubMed ID: 30066579
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the long-held secrets of the 26S proteasome.
Förster F; Unverdorben P; Sledź P; Baumeister W
Structure; 2013 Sep; 21(9):1551-62. PubMed ID: 24010714
[TBL] [Abstract][Full Text] [Related]
8. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X
Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333
[TBL] [Abstract][Full Text] [Related]
9. Human Telomerase Reverse Transcriptase (hTERT) Positively Regulates 26S Proteasome Activity.
Im E; Yoon JB; Lee HW; Chung KC
J Cell Physiol; 2017 Aug; 232(8):2083-2093. PubMed ID: 27648923
[TBL] [Abstract][Full Text] [Related]
10. An historic perspective of proteasome inhibition.
Esseltine DL; Mulligan G
Semin Hematol; 2012 Jul; 49(3):196-206. PubMed ID: 22726542
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a Small Molecule Probe of Rpn-6, an Essential Subunit of the 26S Proteasome.
Tian W; Trader DJ
ACS Chem Biol; 2020 Feb; 15(2):554-561. PubMed ID: 31877015
[TBL] [Abstract][Full Text] [Related]
12. Thiostrepton interacts covalently with Rpt subunits of the 19S proteasome and proteasome substrates.
Sandu C; Chandramouli N; Glickman JF; Molina H; Kuo CL; Kukushkin N; Goldberg AL; Steller H
J Cell Mol Med; 2015 Sep; 19(9):2181-92. PubMed ID: 26033448
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development.
Huber EM; Groll M
Angew Chem Int Ed Engl; 2012 Aug; 51(35):8708-20. PubMed ID: 22711561
[TBL] [Abstract][Full Text] [Related]
14. Hsm3/S5b participates in the assembly pathway of the 19S regulatory particle of the proteasome.
Le Tallec B; Barrault MB; Guérois R; Carré T; Peyroche A
Mol Cell; 2009 Feb; 33(3):389-99. PubMed ID: 19217412
[TBL] [Abstract][Full Text] [Related]
15. Allosteric effects in the regulation of 26S proteasome activities.
Sledź P; Förster F; Baumeister W
J Mol Biol; 2013 May; 425(9):1415-23. PubMed ID: 23416139
[TBL] [Abstract][Full Text] [Related]
16. Small-Molecule Inhibitors of the Proteasome's Regulatory Particle.
Muli CS; Tian W; Trader DJ
Chembiochem; 2019 Jul; 20(14):1739-1753. PubMed ID: 30740849
[TBL] [Abstract][Full Text] [Related]
17. Chaperone-driven proteasome assembly.
Rosenzweig R; Glickman MH
Biochem Soc Trans; 2008 Oct; 36(Pt 5):807-12. PubMed ID: 18793141
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in the Discovery of Novel Peptide Inhibitors Targeting 26S Proteasome.
Gu X; Ma S
Anticancer Agents Med Chem; 2018; 18(12):1656-1673. PubMed ID: 30101718
[TBL] [Abstract][Full Text] [Related]
19. Targeting the ubiquitin proteasome system in haematological malignancies.
Crawford LJ; Irvine AE
Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
[TBL] [Abstract][Full Text] [Related]
20. Molecular model of the human 26S proteasome.
da Fonseca PC; He J; Morris EP
Mol Cell; 2012 Apr; 46(1):54-66. PubMed ID: 22500737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
